• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Jazz Pharmaceuticals Plc

+ Add to Watchlist


136.8100 USD 5.7000 4.00%

As of 20:10:00 ET on 07/28/2014.

Snapshot for Jazz Pharmaceuticals Plc (JAZZ)

Open: 142.6000 Day's Range: 136.2600 - 143.0000 Volume: 1,133,695
Previous Close: 142.5100 52wk Range: 74.0000 - 176.6010 1-Yr Rtn: +84.53%

Stock Chart for JAZZ

No chart data available.
  • JAZZ:US 136.8100
  • 1D
  • 1M
  • 1Y
Interactive JAZZ Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for JAZZ

Current P/E Ratio (ttm) 74.7054
Estimated P/E(12/2014) 16.9845
Relative P/E vs. SPX 4.1256
Earnings Per Share (USD) (ttm) 1.8313
Est. EPS (USD) (12/2014) 8.0550
Est. PEG Ratio 0.7305
Market Cap (M USD) 8,133.47
Shares Outstanding (M) 59.45
30 Day Average Volume 854,041
Price/Book (mrq) 6.5061
Price/Sale (ttm) 8.6449
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for JAZZ

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for JAZZ

Jazz Pharmaceuticals plc is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing innovative products that address unmet medical needs. The company has a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry.

Bruce C CozaddChairman/CEO/Co-FounderRussell J CoxExec VP/COO
Suzanne Sawochka HooperExec VP/General CounselJeffrey K Tobias "Jeff"Exec VP:Research & Development
More Company Profile & Key Executives for JAZZ

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil